Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 148 results.
User Information
Export Records
  1. 1.   Functionally diverse thymic medullary epithelial cells interplay to direct central tolerance
  2. Ushio, Aya; Matsuda-Lennikov, Mami; Kalle-Youngoue,Felix; Shimizu, Akihide; Abdelmaksoud, Abdalla; Kelly, Michael C; Ishimaru, Naozumi; Takahama, Yousuke
  3. Cell Reports. 2024, Apr 05; 43(4): 114072.
  1. 2.   Germline pathogenic variants associated with triple-negative breast cancer in US Hispanic and Guatemalan women using hospital and community-based recruitment strategies
  2. Godinez Paredes, Jesica M; Rodriguez, Isabel; Ren, Megan; Orozco, Anali; Ortiz, Jeremy; Albanez, Anaseidy; Jones, Catherine; Nahleh, Zeina; Barreda, Lilian; Garland,Lisa; Torres-Gonzalez, Edmundo; Wu,Dongjing; Luo,Wen; Liu,Jia; Argueta, Victor; Orozco, Roberto; Gharzouzi, Eduardo; Dean, Michael
  3. Breast Cancer Research and Treatment. 2024, Mar 23;
  1. 3.   Early Intervention in STAT3 Dominant-Negative Disease
  2. An, Zixiao Annie; Williams, Kelli W; Urban,Amanda; Ali, Sania; Roy, Susan; Lafeer, Christine; Heimall, Jennifer; Dimitriades, Victoria R; Davis, Joie; Kong, Heidi H; Cowen, Edward W; Holland, Steven M; Freeman, Alexandra F
  3. The Journal of Allergy and Clinical Immunology. In Practice. 2023, Sep 06;
  1. 4.   A phase 1 and pharmacodynamic study of chronically-dosed, single-agent veliparib (ABT-888) in patients with BRCA1- or BRCA2-mutated cancer or platinum-refractory ovarian or triple-negative breast cancer
  2. Manzo, Julia; Puhalla, Shannon; Pahuja, Shalu; Ding, Fei; Lin, Yan; Appleman, Leonard; Tawbi, Hussein; Stoller, Ronald; Lee, James J; Diergaarde, Brenda; Kiesel, Brian F; Yu, Jing; Tan, Antoinette R; Belani, Chandra P; Chew, Helen; Garcia, Agustin A; Morgan, Robert J; Wahner Hendrickson, Andrea E; Visscher, Daniel W; Hurley, Rachel M; Kaufmann, Scott H; Swisher, Elizabeth M; Oesterreich, Steffi; Katz, Tiffany; Ji,Jay; Zhang, Yiping; Parchment, Ralph E; Chen, Alice; Duan, Wenrui; Giranda, Vincent; Shepherd, Stacie P; Ivy, S Percy; Chu, Edward; Beumer, Jan H
  3. Cancer Chemotherapy and Pharmacology. 2022, Apr 18; 89(5): 721-735.
  1. 5.   Febrile neutropenia management and outcomes in hematopoietic cell transplantation for chronic granulomatous disease
  2. Parta,Mark; Cuellar-Rodriguez, Jennifer; Gea-Banacloche, Juan; Qin, Jing; Kelly, Corin; Zerbe, Christa S; Holland, Steven M; Malech, Harry L; Kang, Elizabeth M
  3. Transplant Infectious Disease : an official journal of the Transplantation Society. 2022, Feb 21;
  1. 6.   Heterodimeric IL-15 (hetIL-15) reduces circulating tumor cells and metastasis formation improving chemotherapy and surgery in 4T1 mouse model of TNBC
  2. Stravokefalou, Vasiliki; Stellas, Dimitris; Karaliota,Sevasti; Nagy,Bethany; Valentin, Antonio; Bergamaschi, Cristina; Dimas, Konstantinos; Pavlakis,George
  3. Frontiers in Immunology. 2022, Jan 13; 13: 1014802.
  1. 7.   beta-Arrestin-1 is required for adaptive beta-cell mass expansion during obesity
  2. Barella, Luiz F.; Rossi, Mario; Pydi, Sai P.; Meister, Jaroslawna; Jain, Shanu; Cui, Yinghong; Gavrilova, Oksana; Fulgenzi, Gianluca; Tessarollo,Lino; Wess, Jurgen
  3. Nature communications. 2021, Jun 7; 12(1):
  1. 8.   Yuanhuacine Is a Potent and Selective Inhibitor of the Basal-Like 2 Subtype of Triple Negative Breast Cancer with Immunogenic Potential
  2. Fermaintt, Charles S.; Peramuna, Thilini; Cai, Shengxin; Takahashi-Ruiz, Leila; Essif, Jacob Nathaniel; Grant, Corena V.; O'Keefe,Barry; Mooberry, Susan L.; Cichewicz, Robert H.; Risinger, April L.
  3. Cancers. 2021, JUN; 13(11):
  1. 9.   Eribulin Regresses a Cisplatinum-resistant Rare-type Triple-negative Matrix-producing Breast Carcinoma Patient-derived Orthotopic Xenograft Mouse Model
  2. Yamamoto, Jun; Murata, Takuya; Sugisawa, Norihiko; Higuchi, Takashi; Tashiro, Yoshihiko; Nishino, Hiroto; Inubushi, Sachiko; Sun, Y U; Lim, Hyein; Miyake, Kentaro; Shimoya, Koichiro; Nomura, Tsunehisa; Kurebayashi, Junichi; Tanino, Hirokazu; Hozumi, Chihiro; Bouvet, Michael; Singh,Shree Ram; Endo, Itaru; Hoffman, Robert M
  3. Anticancer research. 2020, May; 40(5): 2475-2479.
  1. 10.   A Single Low Dose of Eribulin Regressed a Highly Aggressive Triple-negative Breast Cancer in a Patient-derived Orthotopic Xenograft Model
  2. Lim, Hye In; Yamamoto, Jun; Inubushi, Sachiko; Nishino, Hiroto; Tashiro, Yoshihiko; Sugisawa, Norihiko; Han, Quinhong; Sun, Y U; Choi, Hee Jun; Nam, Seok Jin; Kim, Moon Bo; Lee, Ji Sun; Hozumi, Chihiro; Bouvet, Michael; Singh,Shree Ram; Hoffman, Robert M
  3. Anticancer research. 2020, May; 40(5): 2481-2485.
  1. 11.   A Triple-negative Matrix-producing Breast Carcinoma Patient-derived Orthotopic Xenograft (PDOX) Mouse Model Is Sensitive to Bevacizumab and Vinorelbine, Regressed by Eribulin and Resistant to Olaparib
  2. Yamamoto, Jun; Murata, Takuya; Tashiro, Yoshihiko; Higuchi, Takashi; Sugisawa, Norihiko; Nishino, Hiroto; Inubushi, Sachiko; Sun, Y U; Lim, Hyein; Miyake, Kentaro; Hongo, Atsushi; Nomura, Tsunehisa; Saitoh, Wataru; Moriya, Takuya; Tanino, Hirokazu; Hozumi, Chihiro; Bouvet, Michael; Singh,Shree Ram; Endo, Itaru; Hoffman, Robert M
  3. Anticancer research. 2020, May; 40(5): 2509-2514.
  1. 12.   Pharmacoepidemiology of Ceftazidime-Avibactam Use: A Retrospective Cohort Analysis of 210 US Hospitals
  2. Strich, Jeffrey R; Ricotta, Emily; Warner, Sarah; Lai, Yi Ling; Demirkale, Cumhur Y; Hohmann, Samuel F; Rhee, Chanu; Klompas, Michael; Palmore, Tara; Powers,John; Dekker, John P; Adjemian, Jennifer; Matsouaka, Roland; Woods, Christopher W; Danner, Robert L; Kadri, Sameer S
  3. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2020, Feb 28; (4):
  1. 13.   ß-hCG induced mutant BRCA1 ignites drug resistance in susceptible breast tissue
  2. Sengodan,Satheesh; Hemalatha, Sreelatha K; Nadhan, Revathy; Somanathan, Thara; Mathew, Arun Peter; Chil, Arkadiusz; Kopczynski, Janusz; Nair, Rakesh Sathish; Kumar, Jerald Mahesh; Srinivas, Priya
  3. Carcinogenesis. 2019, Nov; 40(11): 1415-1426.
  1. 14.   Triple-negative breast cancer cell line sensitivity to englerin A identifies a new, targetable subtype
  2. Grant, Corena V; Carver, Chase M; Hastings, Shayne D; Ramachandran, Karthik; Muniswamy, Madesh; Risinger, April L; Beutler,John; Mooberry, Susan L
  3. Breast cancer research and treatment. 2019, SEP; 177(2): 345-355.
  1. 15.   A Systems Pharmacology Approach Uncovers Wogonoside as an Angiogenesis Inhibitor of Triple-Negative Breast Cancer by Targeting Hedgehog Signaling
  2. Huang, Yujie; Fang, Jiansong; Lu, Weiqiang; Wang, Zihao; Wang, Qi; Hou, Yuan; Jiang, Xingwu; Reizes, Ofer; Lathia, Justin; Nussinov,Ruth; Eng, Charis; Cheng, Feixiong
  3. Cell chemical biology. 2019, Aug 15; 26(8): 1143-1158.e.
  1. 16.   External Validation of Difficult-to-Treat Resistance Prevalence and Mortality Risk in Gram-Negative Bloodstream Infection Using Electronic Health Record Data From 140 US Hospitals
  2. Kadri, Sameer S; Lai, Yi Ling Elaine; Ricotta, Emily E; Strich, Jeffrey R; Babiker, Ahmed; Rhee, Chanu; Klompas, Michael; Dekker, John P; Powers,John; Danner, Robert L; Adjemian, Jennifer
  3. Open forum infectious diseases. 2019, Apr; 6(4): ofz110.
  1. 17.   Metaplastic breast cancers: Genomic profiling, mutational burden and tumor-infiltrating lymphocytes
  2. Tray, Nancy; Taff, Jessica; Singh, Baljit; Suh, James; Ngo, Nhu; Kwa, Maryann; Troxel, Andrea B; Chae, Young Kwang; Kurzrock, Razelle; Patel, Sandip Pravin; Sharon, Elad; Denkert, Carsten; Ross, Jeffrey S; Adams, Sylvia
  3. Breast (Edinburgh, Scotland). 2019, Apr; 44: 29-32.
  1. 18.   Understanding the tumour micro-environment communication network from an NOS2/COX2 perspective
  2. Basudhar,Debashree; Bharadwaj, Gaurav; Somasundaram,Veena; Cheng,Robert; Ridnour,Lisa; Fujita, Mayumi; Lockett,Stephen; Anderson,Steve; McVicar,Daniel; Wink,David
  3. British Journal of Pharmacology. 2019, Jan; 176(2): 155-176.
  1. 19.   Recombination is required for efficient HIV-1 replication and the maintenance of viral genome integrity
  2. Rawson,Jonathan; Nikolaitchik,Olga; Keele,Brandon; Pathak,Vinay; Hu,Wei-Shau
  3. NUCLEIC ACIDS RESEARCH. 2018, Nov 16; 46(20): 10535-10545.
  1. 20.   Combination therapy of tumor-targeting Salmonella typhimurium A1-R and oral recombinant methioninase regresses a BRAF-V600E-negative melanoma
  2. Kawaguchi, Kei; Higuchi, Takashi; Li, Shukuan; Han, Qinghong; Tan, Yuying; Igarashi, Kentaro; Zhao, Ming; Miyake, Kentaro; Kiyuna, Tasuku; Miyake, Masuyo; Ohshiro, Hiromichi; Sugisawa, Norihiko; Zhang, Zhiying; Razmjooei, Sahar; Wangsiricharoen, Sintawat; Chmielowski, Bartosz; Nelson, Scott D; Russell, Tara A; Dry, Sarah M; Li, Yunfeng; Eckardt, Mark A; Singh, Arun S; Singh, Shree Ram; Eilber, Fritz C; Unno, Michiaki; Hoffman, Robert M
  3. Biochemical and Biophysical Research Communications. 2018, Sep 18; 503(4): 3086-3092.
  1. 21.   Novel cancer gene variants and gene fusions of triple-negative breast cancers (TNBCs) reveal their molecular diversity conserved in the patient-derived xenograft (PDX) model
  2. Jung, Jaeyun; Jang, Kiwon; Ju, Jung Min; Lee, Eunji; Lee, Jong Won; Kim, Hee Jung; Kim, Jisun; Lee, Sae Byul; Ko, Beom Seok; Son, Byung Ho; Lee, Hee Jin; Gong, Gyungyup; Ahn, Sei Yeon; Choi, Jung Kyoon; Singh, Shree Ram; Chang, Suhwan
  3. Cancer Letters. 2018, Aug 01; 428: 127-138.
  1. 22.   Structural analyses of the Haemophilus influenzae peptidoglycan synthase activator LpoA suggest multiple conformations in solution
  2. Sathiyamoorthy, Karthik; Vijayalakshmi, J; Tirupati, Bhramara; Fan, Lixin; Saper, Mark A
  3. The Journal of Biological Chemistry. 2017, Oct 27; 292(43): 17626-17642.
  1. 23.   Phase I/Ib study of olaparib and carboplatin in women with triple negative breast cancer
  2. Lee, Jung-Min; Hays, John L; Chiou, Victoria L; Annunziata, Christina M; Swisher, Elizabeth M; Harrell, Maria I; Yu, Minshu; Gordon, Nicolas; Sissung, Tristan M; Ji, Jay; Figg, William D; Minasian, Lori; Lipkowitz, Stanley; Wood, Bradford J; Doroshow, James; Kohn, Elise C
  3. Oncotarget. 2017, Oct 03; 8(45): 79175-79187.
  1. 24.   ERBIN deficiency links STAT3 and TGF-beta pathway defects with atopy in humans
  2. Lyons, J. J.; Liu, Y.; Ma, C. A.; Yu, X.; O'Connell, M. P.; Lawrence, M. G.; Zhang, Y.; Karpe, K.; Zhao, M.; Siegel, A. M.; Stone, K. D.; Nelson, C.; Jones, Nina; DiMaggio, T.; Darnell, D. N.; Mendoza-Caamal, E.; Orozco, L.; Hughes, J. D.; McElwee, J.; Hohman, R. J.; Frischmeyer-Guerrerio, P. A.; Rothenberg, M. E.; Freeman, A. F.; Holland, S. M.; Milner, J. D.
  3. JOURNAL OF EXPERIMENTAL MEDICINE. 2017, 2017-03-01; 214(3): 669-680.
  1. 25.   Vascular endothelial growth factor receptor 2 inhibition in-vivo affects tumor vasculature in a tumor type-dependent way and downregulates vascular endothelial growth factor receptor 2 protein without a prominent role for miR-296
  2. Langenkamp, E.; Zwiers, P. J.; Moorlag, H. E.; Leenders, W. P.; Croix, B. S.; Molema, G.
  3. Anti-Cancer Drugs. 2012, Feb; 23(2): 161-172.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel